期刊
ISRAEL JOURNAL OF CHEMISTRY
卷 57, 期 7-8, 页码 674-685出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/ijch.201600105
关键词
Alzheimer's disease; amyloid; blood proteins; protein aggregation; transition metals
资金
- Alzheimer Foundation
- Swedish Research Council
- Brain Foundation
- Magnus Bergvall Foundation
This review describes interactions between the amyloid- peptide (A) involved in Alzheimer's disease (AD) and endogenous metal ions and proteins, with an emphasis on future potential drug therapies and targets. AD is characterised by loss of neurons, memory, and cognitive functions, and by formation of cerebral senile plaque deposits. These plaques consist mainly of aggregated A peptides. AD pathology includes a) on the molecular level imbalanced concentrations of A peptides and metal ions, and formation of amyloid structures, and b) on the physiological level a combination of inflammatory responses and oxidative stress effects causing neuronal death. Interestingly, certain blood proteins and metal ions can affect the A amyloid aggregation process. These interactions are the topics of the present review. A deeper understanding of these interactions could facilitate new therapeutic strategies against AD. Previous therapeutic approaches and trials are also briefly described.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据